Contact Us


Technical Services


color photo of lab technician

The BD Global Technical Services department provides assistance with a variety of topics regarding blood and urine collection, phlebotomy, literature, data support and product related questions. We have a knowledgeable and professional team of Medical Technologists on staff, ready to help with your technical product questions.

Contact a Medical Technologist with a technical product question (Not for emergency or medical information):

Phone: 1.800.631.0174
Fax: 201.847.5929
E-mail: Technical Support Contact Form for U.S.


Library of Clinical Support Documentation


  • White Papers - request complimentary white papers

    North America (USA, Canada)

    BD Diagnostics - Preanalytical Systems array of products are clinically proven and supported with over 100 clinical studies on a number of analytes to document efficacy, performance characteristics and ease of use. Unless otherwise noted, the white papers have been researched and written at BD by BD associates.

    Please visit our website periodically to review and request white paper titles to ensure that your facility has the most current version of the document and to view the name of the white papers that have been rendered obsolete by BD.

color photo of phlebotomist
  • View recent updates or order them today:

    • Individual White Papers

    • Clinical Documentation Reference Manuals (CDRM) - are a compilation of white papers by laboratory discipline to support the use of the BD Vacutainer® brand of tubes. The purpose of this manual is to support your facility when addressing your clinical data requirements.

      • These manuals will help you to address the Laboratory Accreditation Program Inspection Checklist by the College of American Pathologists (CAP).

      • CAP Checklist questions #GEN. 40942 Phase 1 states: "Has the laboratory evaluated its specimen containers to ensure that they do not contribute to analytical interference in the assay to be performed?" NOTE: This may be done through some combination of direct testing by the laboratory, review of the clinical literature, and evaluation of information from manufacturers. It does not mandate exhaustive testing by each laboratory. COMMENTARY: The laboratory should evaluate its specimen containers to ensure that they do not contribute to analytic interference in the assays to be performed. This may be done through some combination of direct testing by the laboratory, review of the clinical literature, and evaluation of information from manufacturers. It does not mandate exhaustive testing by each laboratory. "Inertness" of blood collection containers and specimen-contacting transfer devices and aliquot tubes cannot be assumed, as materials within these containers may lead to erroneous test results with medical consequences. Further, over- or under-filling vacuum tubes may lead to error.